|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, 2290-2298, November 2009 Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation[S]
* Departments of Biochemistry, Mass Spectrometry Research Center, Nashville, TN 37232
1 To whom correspondence should be addressed. e-mail: r.caprioli{at}vanderbilt.edu
Molecular events involved in successful embryo implantation are not well understood. In this study, we used MALDI imaging mass spectrometry (IMS) technologies to characterize the spatial and temporal distribution of phospholipid species associated with mouse embryo implantation. Molecular images showing phospholipid distribution within implantation sites changed markedly between distinct cellular areas during days 4–8 of pregnancy. For example, by day 8, linoleate- and docosahexaenoate-containing phospholipids localized to regions destined to undergo cell death, whereas oleate-containing phospholipids localized to angiogenic regions. Arachidonate-containing phospholipids showed different segregation patterns depending on the lipid class, revealing a strong correlation of phosphatidylethanolamines and phosphatidylinositols with cytosolic phospholipase A2
Supplementary key words imaging mass spectrometry phosphatidylcholine sphingomyelins phosphatidylinositol phosphatidylserine phosphatidylglycerol phosphatidylethanolamine Abbreviations: AA, arachidonic acid; AM, antimesometrial; COX, cyclooxygenase; cPLA2
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||